Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD
Browse by category
Surging US medical costs have employers taking a hard look at the return on investment
Novel regulatory mechanism governing reactive oxygen species production associated with metabolic and immune pathway interactions in obesity
Semaglutide linked to uncommon blindness condition NAION
Specific gut bacteria are involved in compulsive eating and obesity
Flagship Pioneering, ProFound Therapeutics and Pfizer to identify novel first-in-class therapeutics for the treatment of obesity
Palatin initiates study of bremelanotide for the treatment of obesity
GLP-1 medications for teens with type 2 diabetes and obesity frequently denied by insurance companies
Increased risk of heart attack and stroke for people living with obesity for a decade or more
New drug candidate targeting mitochondria reverses obesity in mice